| |
Healthy individuals (no products added)
(N = 25)
|
Untreated Diabetes (DIAB)
(N = 69)
|
Diabetes with Deferasirox (DFX)
(N = 69)
|
Diabetes with Deferoxamine (DFO)
(N = 69)
|
|---|
|
Average age and ± SD
|
55 ± 11
|
59 ± 11
|
|
Cells analysed
(
N)
|
3265
|
4365
|
4271
|
4369
|
|
Axial ratio average and ± SD
|
1.14 ± 0.15
|
1.25 ± 0.27
|
1.24 ± 0.26
|
1.27 ± 0.27
|
|
SIGNIFICANT DIFFERENCE BETWEEN GROUPS (p-values shown)
|
|
Healthy/Diab
|
Diab/DFX
|
Diab/DFO
|
DFX/DFO
|
Healthy/DFX
|
Healthy/DFO
|
|
1.1E-56
|
4.7E-02
|
2.6E-04
|
2.6E-04
|
2.9E-83
|
2.0E-02
|
- Data provided for healthy individuals compared with untreated diabetes, diabetes treated with deferasirox (DFX) and deferoxamine (DFO). Untreated diabetes results were also compared (comparison done on a paired basis) with diabetes treated with DFX and DFO.
